XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Interim Statements of Changes in Equity (Unaudited) - USD ($)
$ in Thousands
Ordinary shares [Member]
Additional paid in capital [Member]
Accumulated deficit [Member]
Total
Beginning balance at Dec. 31, 2020 [1] $ 0 $ 34,497 $ (23,695) $ 10,802
Beginning balance (in shares) at Dec. 31, 2020 [1] 9,274,838      
Share-based compensation $ 0 $ 43 $ 0 $ 43
Effect of reverse capitalization transaction - 2,476 - 2,476
Effect of reverse capitalization transaction (in shares) 152,299,702      
Issuance of shares and warrants, net of issuance costs $ 0 $ 43,547 $ 0 $ 43,547
Issuance of shares and warrants, net of issuance costs (In shares) 52,385,400      
Net loss for the period $ 0 0 (1,704) (1,704)
Ending balance at Mar. 31, 2021 $ 0 80,563 (25,399) 55,164
Ending balance (in shares) at Mar. 31, 2021 213,959,940      
Beginning balance at Dec. 31, 2021 [2] $ 0 97,639 (36,173) 61,466
Beginning balance (in shares) at Dec. 31, 2021 [2] 228,090,300      
Share-based compensation $ 0 874 0 874
Net loss for the period 0 0 (5,104) (5,104)
Ending balance at Mar. 31, 2022 $ 0 $ 98,513 $ (41,277) $ 57,236
Ending balance (in shares) at Mar. 31, 2022 228,090,300      
[1] Number of shares has been retroactively adjusted to reflect the share reverse split effected on March 16, 2021 (refer to Note 1B).
[2] Number and type of equity instruments reflects the capital of the legal parent (the Company).